Bioregenx (BRGX) Depreciation & Amortization (CF) (2023 - 2026)
Bioregenx (BRGX) recorded quarterly Depreciation & Amortization (CF) of $12943.0 in Q1 2026, down 65.89% quarter-over-quarter from $37945.0 in Q4 2025, and up 4.57% on a YoY basis from $12377.0 in Q1 2025.
Bioregenx (BRGX) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Bioregenx's Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $12943.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 4.57% year-over-year to $12943.0; the TTM figure through Mar 2026 stood at $100642.0 (down 94.19% YoY), while the FY2025 annual figure was $75075.0, down 96.62% from the prior year.
- Depreciation & Amortization (CF) was $12943.0 for Q1 2026 at Bioregenx, down from $37945.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $574466.0 in Q3 2024 to a low of $1193.0 in Q2 2023.
- Historically, Depreciation & Amortization (CF) has averaged $179768.2 across 4 years, with a median of $12943.0 in 2026.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) soared 48053.06% in 2024, then tumbled 97.85% in 2025.
- A 4-year view of Depreciation & Amortization (CF) shows it stood at $1194.0 in 2023, then soared by 48012.73% to $574466.0 in 2024, then tumbled by 93.39% to $37945.0 in 2025, then plunged by 65.89% to $12943.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $12943.0 (Q1 2026), $37945.0 (Q4 2025), and $12377.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 11.59 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 39.09 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 38.21 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 1.17 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 9.96 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 4.13 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 41.45 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 146,000.00 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 18.60 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | 12,943.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,943.00 |
| Mar 31, 2026 | 12,943.00 |
| Dec 31, 2025 | 37,945.00 |
| Dec 31, 2025 | 37,945.00 |
| Sep 30, 2025 | 12,377.00 |
| Sep 30, 2025 | 12,377.00 |
| Jun 30, 2025 | 37,377.00 |
| Jun 30, 2025 | 37,377.00 |
| Mar 31, 2025 | 12,377.00 |
| Mar 31, 2025 | 12,377.00 |
| Dec 31, 2024 | 574,466.00 |
| Dec 31, 2024 | 574,466.00 |
| Sep 30, 2024 | 574,466.00 |
| Sep 30, 2024 | 574,466.00 |
| Jun 30, 2024 | 569,731.00 |
| Jun 30, 2024 | 569,731.00 |
| Mar 31, 2024 | 500,530.00 |
| Mar 31, 2024 | 500,530.00 |
| Dec 31, 2023 | 1,194.00 |
| Dec 31, 2023 | 1,194.00 |